Boehringer Ingelheim International GmbH
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference 34c1e2a81d
Drug names50First applicant · distinct drug namesAcceptance records440First applicant · distinct acceptance numbersUnder-review numbers23First applicant · current under-review listCo-applicant records18Subsequent applicant only · separate count
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/11 06:42.
Drug filings
440 acceptance records as first applicant, grouped into 50 source drug names. Source data as of 2026/11/11 06:42.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
No verified English name 1 records · Latest accepted 2026/11/09
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSL2600307 | Import | 2026/11/09 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
No verified English name 91 records · Latest accepted 2026/10/13
Import · 65Supplement · 26
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHL2600448 | Import | 2026/10/13 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600447 | Import | 2026/10/13 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600446 | Import | 2026/10/13 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600445 | Import | 2026/10/13 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600444 | Import | 2026/10/13 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600443 | Import | 2026/10/13 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600442 | Import | 2026/10/13 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHB2500145 | Supplement | 2025/10/18 | Boehringer Ingelheim International GmbH; Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2500144 | Supplement | 2025/10/18 | Boehringer Ingelheim International GmbH; Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2500143 | Supplement | 2025/10/18 | Boehringer Ingelheim International GmbH; Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2500142 | Supplement | 2025/10/18 | Boehringer Ingelheim International GmbH; Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2500141 | Supplement | 2025/10/18 | Boehringer Ingelheim International GmbH; Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2500140 | Supplement | 2025/10/18 | Boehringer Ingelheim International GmbH; Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2500139 | Supplement | 2025/10/18 | Boehringer Ingelheim International GmbH; Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2400165 | Supplement | 2024/09/30 | Boehringer Ingelheim International GmbH; Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2400164 | Supplement | 2024/09/30 | Boehringer Ingelheim International GmbH; Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2400163 | Supplement | 2024/09/30 | Boehringer Ingelheim International GmbH; Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2400162 | Supplement | 2024/09/30 | Boehringer Ingelheim International GmbH; Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2400161 | Supplement | 2024/09/30 | Boehringer Ingelheim International GmbH; Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2400160 | Supplement | 2024/09/30 | Boehringer Ingelheim International GmbH; Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2400159 | Supplement | 2024/09/30 | Boehringer Ingelheim International GmbH; Vetter Development Services USA Inc. | CDE ↗ |
| JXHL2400197 | Import | 2024/08/07 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400196 | Import | 2024/08/07 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400195 | Import | 2024/08/07 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400194 | Import | 2024/08/07 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400193 | Import | 2024/08/07 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400192 | Import | 2024/08/07 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400191 | Import | 2024/08/07 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400190 | Import | 2024/08/07 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400189 | Import | 2024/08/07 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400188 | Import | 2024/08/07 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400187 | Import | 2024/08/07 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400186 | Import | 2024/08/07 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400185 | Import | 2024/08/07 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400184 | Import | 2024/08/07 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHB2400108 | Supplement | 2024/06/14 | Boehringer Ingelheim International GmbH; Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2400107 | Supplement | 2024/06/14 | Boehringer Ingelheim International GmbH; Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2400106 | Supplement | 2024/06/14 | Boehringer Ingelheim International GmbH; Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2400105 | Supplement | 2024/06/14 | Boehringer Ingelheim International GmbH; Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2400104 | Supplement | 2024/06/14 | Boehringer Ingelheim International GmbH; Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2400103 | Supplement | 2024/06/14 | Boehringer Ingelheim International GmbH; Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2400102 | Supplement | 2024/06/14 | Boehringer Ingelheim International GmbH; Vetter Development Services USA Inc. | CDE ↗ |
| JXHL2400020 | Import | 2024/01/19 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400019 | Import | 2024/01/19 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400018 | Import | 2024/01/19 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400017 | Import | 2024/01/19 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400016 | Import | 2024/01/19 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400015 | Import | 2024/01/19 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400014 | Import | 2024/01/19 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300244 | Import | 2023/09/22 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300243 | Import | 2023/09/22 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300242 | Import | 2023/09/22 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300241 | Import | 2023/09/22 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300240 | Import | 2023/09/22 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300239 | Import | 2023/09/22 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300235 | Import | 2023/09/19 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300234 | Import | 2023/09/19 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300233 | Import | 2023/09/19 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300232 | Import | 2023/09/19 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300231 | Import | 2023/09/18 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300230 | Import | 2023/09/18 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300229 | Import | 2023/09/18 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300223 | Import | 2023/09/12 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300222 | Import | 2023/09/12 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300221 | Import | 2023/09/12 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300220 | Import | 2023/09/12 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300219 | Import | 2023/09/12 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300218 | Import | 2023/09/12 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300217 | Import | 2023/09/12 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300216 | Import | 2023/09/12 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300215 | Import | 2023/09/12 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300214 | Import | 2023/09/12 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300213 | Import | 2023/09/12 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300212 | Import | 2023/09/12 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300211 | Import | 2023/09/12 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300210 | Import | 2023/09/12 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHB2200142 | Supplement | 2022/09/18 | Boehringer Ingelheim International GmbH; Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2200141 | Supplement | 2022/09/18 | Boehringer Ingelheim International GmbH; Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2200140 | Supplement | 2022/09/18 | Boehringer Ingelheim International GmbH; Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2200139 | Supplement | 2022/09/18 | Boehringer Ingelheim International GmbH; Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2200138 | Supplement | 2022/09/18 | Boehringer Ingelheim International GmbH; Vetter Development Services USA Inc. | CDE ↗ |
| JXHL2101064 | Import | 2021/05/27 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2101063 | Import | 2021/05/27 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2101062 | Import | 2021/05/27 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2101061 | Import | 2021/05/27 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2101060 | Import | 2021/05/27 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2000360 | Import | 2021/01/05 | Boehringer Ingelheim International GmbH | CDE ↗ |
| JXHL2000359 | Import | 2021/01/05 | Boehringer Ingelheim International GmbH | CDE ↗ |
| JXHL2000358 | Import | 2021/01/05 | Boehringer Ingelheim International GmbH | CDE ↗ |
| JXHL2000357 | Import | 2021/01/05 | Boehringer Ingelheim International GmbH | CDE ↗ |
| JXHL2000356 | Import | 2021/01/05 | Boehringer Ingelheim International GmbH | CDE ↗ |
No verified English name 10 records · Latest accepted 2026/09/23
Import · 10
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHL2600416 | Import | 2026/09/23 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600415 | Import | 2026/09/23 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600414 | Import | 2026/09/23 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600413 | Import | 2026/09/23 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600412 | Import | 2026/09/23 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600109 | Import | 2026/04/09 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600108 | Import | 2026/04/09 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600107 | Import | 2026/04/09 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600106 | Import | 2026/04/09 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600105 | Import | 2026/04/09 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
No verified English name 2 records · Latest accepted 2026/09/03
Import · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHL2600392 | Import | 2026/09/03 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2600012 | Import | 2026/01/16 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
Nintedanib Esilate Soft Capsules 14 records · Latest accepted 2026/08/12
Import re-registration · 4Supplement · 10
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHZ2600193 | Import re-registration | 2026/08/12 | Boehringer Ingelheim International GmbH; Catalent Germany Eberbach GmbH | CDE ↗ |
| JYHZ2600192 | Import re-registration | 2026/08/12 | Boehringer Ingelheim International GmbH; Catalent Germany Eberbach GmbH | CDE ↗ |
| JYHB2500616 | Supplement | 2025/11/12 | Boehringer Ingelheim International GmbH; Catalent Germany Eberbach GmbH; Catalent France Beinheim | CDE ↗ |
| JYHB2500615 | Supplement | 2025/11/12 | Boehringer Ingelheim International GmbH; Catalent Germany Eberbach GmbH; Catalent France Beinheim | CDE ↗ |
| JYHB2400549 | Supplement | 2024/10/15 | Boehringer Ingelheim International GmbH; Catalent Germany Eberbach GmbH | CDE ↗ |
| JYHB2400548 | Supplement | 2024/10/15 | Boehringer Ingelheim International GmbH; Catalent Germany Eberbach GmbH | CDE ↗ |
| JYHB2400482 | Supplement | 2024/09/04 | Boehringer Ingelheim International GmbH; Catalent Germany Eberbach GmbH | CDE ↗ |
| JYHB2400481 | Supplement | 2024/09/04 | Boehringer Ingelheim International GmbH; Catalent Germany Eberbach GmbH | CDE ↗ |
| JYHB2200573 | Supplement | 2022/10/25 | Boehringer Ingelheim International GmbH; Catalent Germany Eberbach GmbH | CDE ↗ |
| JYHB2200572 | Supplement | 2022/10/25 | Boehringer Ingelheim International GmbH; Catalent Germany Eberbach GmbH | CDE ↗ |
| JYHZ2100750 | Import re-registration | 2021/12/31 | Boehringer Ingelheim International GmbH; Catalent Germany Eberbach GmbH | CDE ↗ |
| JYHZ2100749 | Import re-registration | 2021/12/31 | Boehringer Ingelheim International GmbH; Catalent Germany Eberbach GmbH | CDE ↗ |
| JYHB2100109 | Supplement | 2021/01/30 | Boehringer Ingelheim International GmbH; Catalent Germany Eberbach GmbH | CDE ↗ |
| JYHB2100108 | Supplement | 2021/01/30 | Boehringer Ingelheim International GmbH; Catalent Germany Eberbach GmbH | CDE ↗ |
Afatinib Dimaleate Tablets 24 records · Latest accepted 2026/08/05
Supplement · 14Import re-registration · 10
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2600436 | Supplement | 2026/08/05 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2600435 | Supplement | 2026/08/05 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHZ2500255 | Import re-registration | 2025/11/11 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2500254 | Import re-registration | 2025/11/11 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2500253 | Import re-registration | 2025/11/11 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2500252 | Import re-registration | 2025/11/11 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHB2500473 | Supplement | 2025/09/05 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2500472 | Supplement | 2025/09/05 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2200630 | Supplement | 2022/11/15 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2200629 | Supplement | 2022/11/15 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2200628 | Supplement | 2022/11/15 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2200627 | Supplement | 2022/11/15 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2200626 | Supplement | 2022/11/15 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2200625 | Supplement | 2022/11/15 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2200098 | Supplement | 2022/02/25 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2200097 | Supplement | 2022/02/25 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2200096 | Supplement | 2022/02/25 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2200095 | Supplement | 2022/02/25 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHZ2100505 | Import re-registration | 2021/03/12 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2100504 | Import re-registration | 2021/03/12 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2100503 | Import re-registration | 2021/03/12 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2100502 | Import re-registration | 2021/03/12 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2100501 | Import re-registration | 2021/03/12 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2100500 | Import re-registration | 2021/03/12 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
No verified English name 9 records · Latest accepted 2026/07/02
Not stated by source · 1Supplement · 4Import re-registration · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JTH2600126 | Not stated by source | 2026/07/02 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharmaceuticals Inc.; Chuan Si Bio Technology (Shanghai) Co., Ltd. romanized | CDE ↗ |
| JYHB2600037 | Supplement | 2026/01/13 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2600036 | Supplement | 2026/01/13 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHZ2300455 | Import re-registration | 2023/12/14 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2300454 | Import re-registration | 2023/12/14 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2300422 | Import re-registration | 2023/11/03 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2300421 | Import re-registration | 2023/11/03 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHB2101450 | Supplement | 2021/09/29 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2101449 | Supplement | 2021/09/29 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
No verified English name 3 records · Latest accepted 2026/06/17
Supplement · 2Import re-registration · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2600333 | Supplement | 2026/06/17 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2500306 | Supplement | 2025/06/06 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim Espa？a S.A. | CDE ↗ |
| JYHZ2200292 | Import re-registration | 2022/10/28 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
No verified English name 13 records · Latest accepted 2026/06/16
Import · 11Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHL2600221 | Import | 2026/06/16 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2600220 | Import | 2026/06/16 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHB2600221 | Supplement | 2026/04/18 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2600220 | Supplement | 2026/04/18 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHL2600116 | Import | 2026/04/17 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2600115 | Import | 2026/04/17 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2600090 | Import | 2026/03/23 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2600089 | Import | 2026/03/23 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2600088 | Import | 2026/03/23 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHS2500058 | Import | 2025/05/15 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHS2500057 | Import | 2025/05/15 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHS2500030 | Import | 2025/02/25 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHS2500029 | Import | 2025/02/25 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
No verified English name 5 records · Latest accepted 2026/06/10
Supplement · 2Import · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2600151 | Supplement | 2026/06/10 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co.KG | CDE ↗ |
| JXSL2600112 | Import | 2026/05/09 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXSL2500155 | Import | 2025/08/14 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXSS2400001 | Import | 2024/01/23 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXSB2200126 | Supplement | 2022/10/11 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co.KG | CDE ↗ |
Telmisartan Tablets 12 records · Latest accepted 2026/04/28
Import re-registration · 8Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHZ2600106 | Import re-registration | 2026/04/28 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Hellas Single Member S.A.; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2600105 | Import re-registration | 2026/04/28 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Hellas Single Member S.A.; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2600104 | Import re-registration | 2026/04/28 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Hellas Single Member S.A.; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2600103 | Import re-registration | 2026/04/28 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Hellas Single Member S.A.; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHB2500220 | Supplement | 2025/04/14 | Boehringer Ingelheim International GmbH; Name not romanized | CDE ↗ |
| JYHB2500219 | Supplement | 2025/04/14 | Boehringer Ingelheim International GmbH; Name not romanized | CDE ↗ |
| JYHB2300703 | Supplement | 2023/12/08 | Boehringer Ingelheim International GmbH; Name not romanized | CDE ↗ |
| JYHB2300702 | Supplement | 2023/12/08 | Boehringer Ingelheim International GmbH; Name not romanized | CDE ↗ |
| JYHZ2100626 | Import re-registration | 2021/09/16 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Ellas A.E. | CDE ↗ |
| JYHZ2100625 | Import re-registration | 2021/09/16 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Ellas A.E. | CDE ↗ |
| JYHZ2100624 | Import re-registration | 2021/09/16 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Ellas A.E. | CDE ↗ |
| JYHZ2100623 | Import re-registration | 2021/09/16 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Ellas A.E. | CDE ↗ |
Empagliflozin Tablets 31 records · Latest accepted 2026/04/01
Import re-registration · 7Supplement · 20Import · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHZ2600076 | Import re-registration | 2026/04/01 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim Seiyaku Co. Ltd.; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2600075 | Import re-registration | 2026/04/01 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim Seiyaku Co. Ltd.; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHB2500684 | Supplement | 2025/12/11 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim Seiyaku Co. Ltd. | CDE ↗ |
| JYHB2500683 | Supplement | 2025/12/11 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim Seiyaku Co. Ltd. | CDE ↗ |
| JYHB2400612 | Supplement | 2024/11/25 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim Seiyaku Co. Ltd | CDE ↗ |
| JYHB2400611 | Supplement | 2024/11/25 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim Seiyaku Co. Ltd | CDE ↗ |
| JYHB2400610 | Supplement | 2024/11/25 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim Seiyaku Co. Ltd. | CDE ↗ |
| JYHB2400609 | Supplement | 2024/11/25 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim Seiyaku Co. Ltd | CDE ↗ |
| JYHB2400608 | Supplement | 2024/11/25 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim Seiyaku Co. Ltd. | CDE ↗ |
| JYHB2300717 | Supplement | 2023/12/14 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2300716 | Supplement | 2023/12/14 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2300083 | Supplement | 2023/02/01 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2300082 | Supplement | 2023/02/01 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHS2300001 | Import | 2023/01/05 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHS2200071 | Import | 2022/08/18 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co.，Ltd. | CDE ↗ |
| JXHS2200070 | Import | 2022/08/18 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co.，Ltd. | CDE ↗ |
| JYHB2200337 | Supplement | 2022/07/02 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2200336 | Supplement | 2022/07/02 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2200210 | Supplement | 2022/04/18 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim Seiyaku Co. Ltd. | CDE ↗ |
| JYHB2200214 | Supplement | 2022/04/15 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim Seiyaku Co. Ltd. | CDE ↗ |
| JYHB2200213 | Supplement | 2022/04/15 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim Seiyaku Co. Ltd. | CDE ↗ |
| JYHB2200212 | Supplement | 2022/04/15 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim Seiyaku Co. Ltd. | CDE ↗ |
| JYHB2200211 | Supplement | 2022/04/15 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim Seiyaku Co. Ltd. | CDE ↗ |
| JXHS2101074 | Import | 2021/11/17 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2100609 | Import re-registration | 2021/08/16 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2100608 | Import re-registration | 2021/08/16 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2100607 | Import re-registration | 2021/08/16 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2100606 | Import re-registration | 2021/08/16 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2100605 | Import re-registration | 2021/08/16 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHB2101032 | Supplement | 2021/06/28 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHB2101031 | Supplement | 2021/06/28 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
Dabigatran Etexilate Capsules 14 records · Latest accepted 2026/03/10
Supplement · 6Import re-registration · 8
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2600154 | Supplement | 2026/03/10 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co.KG | CDE ↗ |
| JYHB2600153 | Supplement | 2026/03/10 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co.KG | CDE ↗ |
| JYHZ2500229 | Import re-registration | 2025/10/21 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co.KG; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2500228 | Import re-registration | 2025/10/21 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co.KG; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2500227 | Import re-registration | 2025/10/21 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co.KG; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2500226 | Import re-registration | 2025/10/21 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co.KG; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHB2101612 | Supplement | 2021/12/22 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2101611 | Supplement | 2021/12/22 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2101610 | Supplement | 2021/12/22 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2101609 | Supplement | 2021/12/22 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHZ2100516 | Import re-registration | 2021/04/16 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2100515 | Import re-registration | 2021/04/16 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2100514 | Import re-registration | 2021/04/16 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2100513 | Import re-registration | 2021/04/16 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
Linagliptin Tablets 10 records · Latest accepted 2026/02/26
Import re-registration · 4Supplement · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHZ2600047 | Import re-registration | 2026/02/26 | Boehringer Ingelheim International GmbH; West-Ward Columbus Inc.; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2600046 | Import re-registration | 2026/02/26 | Boehringer Ingelheim International GmbH; West-Ward Columbus Inc.; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHB2500095 | Supplement | 2025/02/27 | Boehringer Ingelheim International GmbH; West-Ward Columbus Inc. | CDE ↗ |
| JYHB2400311 | Supplement | 2024/06/21 | Boehringer Ingelheim International GmbH; West-Ward Columbus Inc.; Boehringer Ingelheim Seiyaku Co. Ltd. | CDE ↗ |
| JYHB2400310 | Supplement | 2024/06/21 | Boehringer Ingelheim International GmbH; West-Ward Columbus Inc.; Boehringer Ingelheim Seiyaku Co. Ltd. | CDE ↗ |
| JYHB2300302 | Supplement | 2023/05/23 | Boehringer Ingelheim International GmbH; West-Ward Columbus Inc. | CDE ↗ |
| JYHB2300301 | Supplement | 2023/05/23 | Boehringer Ingelheim International GmbH; West-Ward Columbus Inc. | CDE ↗ |
| JYHZ2100571 | Import re-registration | 2021/07/06 | Boehringer Ingelheim International GmbH; West-Ward Columbus Inc.; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2100570 | Import re-registration | 2021/07/06 | Boehringer Ingelheim International GmbH; West-Ward Columbus Inc.; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHB2100110 | Supplement | 2021/02/03 | Boehringer Ingelheim International GmbH; West-Ward Columbus Inc. | CDE ↗ |
No verified English name 3 records · Latest accepted 2026/02/06
Import · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHL2600032 | Import | 2026/02/06 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600008 | Import | 2026/01/09 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHS2500124 | Import | 2025/10/31 | Boehringer Ingelheim International GmbH; Hovione Farmaciencia S.A.; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
No verified English name 2 records · Latest accepted 2026/01/20
Import · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHL2600018 | Import | 2026/01/20 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2600017 | Import | 2026/01/20 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2026/01/16
Import · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHL2600016 | Import | 2026/01/16 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim （China）Investment Co. Ltd. | CDE ↗ |
| JXHL2500328 | Import | 2025/10/23 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
No verified English name 6 records · Latest accepted 2026/01/14
Import re-registration · 4Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHZ2600003 | Import re-registration | 2026/01/14 | Boehringer Ingelheim International GmbH; Dragenopharm Apotheker Püschl GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2600002 | Import re-registration | 2026/01/14 | Boehringer Ingelheim International GmbH; Dragenopharm Apotheker Püschl GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHB2500137 | Supplement | 2025/03/11 | Boehringer Ingelheim International GmbH; Dragenopharm Apotheker Püschl GmbH | CDE ↗ |
| JYHZ2100518 | Import re-registration | 2021/04/16 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co.KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2100517 | Import re-registration | 2021/04/16 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co.KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHB2100070 | Supplement | 2021/01/19 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co.KG | CDE ↗ |
No verified English name 3 records · Latest accepted 2026/01/06
Supplement · 2Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHB2600002 | Supplement | 2026/01/06 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHB2500134 | Supplement | 2025/09/25 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHL2500035 | Import | 2025/03/06 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
No verified English name 3 records · Latest accepted 2025/12/04
Import · 2Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSL2500236 | Import | 2025/12/04 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXSB2400069 | Supplement | 2024/06/05 | Boehringer Ingelheim International GmbH; Vetter Pharma-Fertigung GmbH & Co. KG | CDE ↗ |
| JXSL2300096 | Import | 2023/05/18 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
No verified English name 5 records · Latest accepted 2025/11/13
Supplement · 3Import re-registration · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2500619 | Supplement | 2025/11/13 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHZ2500019 | Import re-registration | 2025/02/06 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2500018 | Import re-registration | 2025/02/06 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHB2400633 | Supplement | 2024/12/10 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim Espa？a S.A. | CDE ↗ |
| JYHB2400632 | Supplement | 2024/12/10 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim Espa？a S.A. | CDE ↗ |
No verified English name 5 records · Latest accepted 2025/09/29
Supplement · 3Import · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2500238 | Supplement | 2025/09/29 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYSB2500043 | Supplement | 2025/02/25 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXSB2400028 | Supplement | 2024/03/15 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXSL2400021 | Import | 2024/01/20 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXSS2300039 | Import | 2023/05/25 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
No verified English name 24 records · Latest accepted 2025/09/04
Import · 7Supplement · 17
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHL2500256 | Import | 2025/09/04 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHB2500065 | Supplement | 2025/05/13 | Boehringer Ingelheim International GmbH; Hovione FarmaCiencia SA; Seran BioScience LLC | CDE ↗ |
| JXHB2500046 | Supplement | 2025/04/14 | Boehringer Ingelheim International GmbH; Hovione FarmaCiencia SA; Seran BioScience LLC | CDE ↗ |
| JXHB2500036 | Supplement | 2025/04/08 | Boehringer Ingelheim International GmbH; Hovione FarmaCiencia SA; Seran BioScience LLC | CDE ↗ |
| JXHB2500004 | Supplement | 2025/02/08 | Boehringer Ingelheim International GmbH; Hovione FarmaCiencia SA | CDE ↗ |
| JXHL2400099 | Import | 2024/05/08 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2400030 | Import | 2024/02/06 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2300279 | Import | 2023/11/09 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHB2300162 | Supplement | 2023/10/14 | Boehringer Ingelheim International GmbH; Seran BioScience LLC; Hovione FarmaCiencia SA | CDE ↗ |
| JXHB2300161 | Supplement | 2023/10/14 | Boehringer Ingelheim International GmbH; Seran BioScience LLC | CDE ↗ |
| JXHB2300112 | Supplement | 2023/07/03 | Boehringer Ingelheim International GmbH; Seran BioScience LLC; Hovione FarmaCiencia SA | CDE ↗ |
| JXHB2300111 | Supplement | 2023/06/28 | Boehringer Ingelheim International GmbH; Seran BioScience LLC | CDE ↗ |
| JXHB2300110 | Supplement | 2023/06/28 | Boehringer Ingelheim International GmbH; CoreRX Inc. | CDE ↗ |
| JXHB2300109 | Supplement | 2023/06/28 | Boehringer Ingelheim International GmbH; CoreRX Inc. | CDE ↗ |
| JXHB2300108 | Supplement | 2023/06/28 | Boehringer Ingelheim International GmbH; CoreRX Inc. | CDE ↗ |
| JXHB2300107 | Supplement | 2023/06/28 | Boehringer Ingelheim International GmbH; Seran BioScience LLC | CDE ↗ |
| JXHB2200136 | Supplement | 2022/09/10 | Boehringer Ingelheim International GmbH; Serán BioScience LLC | CDE ↗ |
| JXHB2200135 | Supplement | 2022/09/10 | Boehringer Ingelheim International GmbH; CoreRX Inc. | CDE ↗ |
| JXHB2200134 | Supplement | 2022/09/10 | Boehringer Ingelheim International GmbH; CoreRX Inc. | CDE ↗ |
| JXHB2200133 | Supplement | 2022/09/10 | Boehringer Ingelheim International GmbH; CoreRX Inc. | CDE ↗ |
| JXHB2200132 | Supplement | 2022/09/10 | Boehringer Ingelheim International GmbH; Serán BioScience LLC | CDE ↗ |
| JXHL2101108 | Import | 2021/06/28 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2101107 | Import | 2021/06/28 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2101106 | Import | 2021/06/28 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
No verified English name 12 records · Latest accepted 2025/06/17
Import · 9Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHL2500147 | Import | 2025/06/17 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2500146 | Import | 2025/06/17 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2500145 | Import | 2025/06/17 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300153 | Import | 2023/06/30 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300152 | Import | 2023/06/30 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300151 | Import | 2023/06/30 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHB2300013 | Supplement | 2023/01/11 | Boehringer Ingelheim International GmbH; Almac Pharma Services Limited | CDE ↗ |
| JXHB2300012 | Supplement | 2023/01/11 | Boehringer Ingelheim International GmbH; Almac Pharma Services Limited | CDE ↗ |
| JXHB2300011 | Supplement | 2023/01/11 | Boehringer Ingelheim International GmbH; Almac Pharma Services Limited | CDE ↗ |
| JXHL2200139 | Import | 2022/06/10 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2200138 | Import | 2022/06/10 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2200137 | Import | 2022/06/10 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
No verified English name 7 records · Latest accepted 2025/06/11
Import · 7
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHL2500132 | Import | 2025/06/11 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2500073 | Import | 2025/04/09 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2500072 | Import | 2025/04/09 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400106 | Import | 2024/05/11 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400105 | Import | 2024/05/10 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2101237 | Import | 2021/11/09 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2101236 | Import | 2021/11/09 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2025/05/16
Supplement · 1Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSB2500040 | Supplement | 2025/05/16 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXSL2300162 | Import | 2023/09/01 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
No verified English name 14 records · Latest accepted 2025/05/01
Supplement · 6Import · 8
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHB2500054 | Supplement | 2025/05/01 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHB2500053 | Supplement | 2025/05/01 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHB2500015 | Supplement | 2025/03/20 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHB2500014 | Supplement | 2025/03/20 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHL2400210 | Import | 2024/08/28 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400209 | Import | 2024/08/28 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300264 | Import | 2023/10/21 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300263 | Import | 2023/10/21 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHB2300079 | Supplement | 2023/05/09 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHB2300078 | Supplement | 2023/05/09 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHL2200219 | Import | 2022/08/01 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2200218 | Import | 2022/08/01 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2200217 | Import | 2022/07/26 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2200216 | Import | 2022/07/26 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2025/04/09
Import · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHL2500075 | Import | 2025/04/09 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (Cnina) Investment Co. Ltd. | CDE ↗ |
| JXHL2500074 | Import | 2025/04/09 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (Cnina) Investment Co. Ltd. | CDE ↗ |
No verified English name 8 records · Latest accepted 2025/02/25
Supplement · 2Import · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2500042 | Supplement | 2025/02/25 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXSL2400145 | Import | 2024/08/03 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXSB2400029 | Supplement | 2024/03/15 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXSL2400020 | Import | 2024/01/20 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXSL2300042 | Import | 2023/02/24 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXSL2300041 | Import | 2023/02/24 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXSL2300022 | Import | 2023/01/12 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXSL2300021 | Import | 2023/01/12 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
No verified English name 4 records · Latest accepted 2025/02/18
Supplement · 3Import re-registration · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2500040 | Supplement | 2025/02/18 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co.KG | CDE ↗ |
| JYSZ2200038 | Import re-registration | 2022/08/03 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co.KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYSB2101218 | Supplement | 2021/12/31 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co.KG | CDE ↗ |
| JYSB2101110 | Supplement | 2021/08/25 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co.KG | CDE ↗ |
Pramipexole Dihydrochloride Tablets 14 records · Latest accepted 2025/01/27
Supplement · 10Import re-registration · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2500053 | Supplement | 2025/01/27 | Boehringer Ingelheim International GmbH; Rottendorf Pharma GmbH | CDE ↗ |
| JYHB2500052 | Supplement | 2025/01/27 | Boehringer Ingelheim International GmbH; Rottendorf Pharma GmbH | CDE ↗ |
| JYHB2500051 | Supplement | 2025/01/27 | Boehringer Ingelheim International GmbH; Rottendorf Pharma GmbH | CDE ↗ |
| JYHB2500050 | Supplement | 2025/01/27 | Boehringer Ingelheim International GmbH; Rottendorf Pharma GmbH | CDE ↗ |
| JYHB2400398 | Supplement | 2024/07/26 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2400397 | Supplement | 2024/07/26 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2400396 | Supplement | 2024/07/26 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2400156 | Supplement | 2024/04/11 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2400155 | Supplement | 2024/04/11 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2400154 | Supplement | 2024/04/11 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHZ2400007 | Import re-registration | 2024/01/10 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2400006 | Import re-registration | 2024/01/10 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2400005 | Import re-registration | 2024/01/10 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2400004 | Import re-registration | 2024/01/10 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/01/15
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHS2500002 | Import | 2025/01/15 | Boehringer Ingelheim International GmbH; Hovione Farmaciencia S.A.; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
Telmisartan and Hydrochlorothiazide Tablets 5 records · Latest accepted 2025/01/08
Supplement · 3Import re-registration · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2500006 | Supplement | 2025/01/08 | Boehringer Ingelheim International GmbH; Name not romanized | CDE ↗ |
| JYHB2400676 | Supplement | 2024/12/25 | Boehringer Ingelheim International GmbH; Name not romanized | CDE ↗ |
| JYHZ2300357 | Import re-registration | 2023/09/04 | Boehringer Ingelheim International GmbH; Name not romanized; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2300356 | Import re-registration | 2023/09/04 | Boehringer Ingelheim International GmbH; Name not romanized; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHB2200591 | Supplement | 2022/11/01 | Boehringer Ingelheim International GmbH; Name not romanized | CDE ↗ |
No verified English name 1 records · Latest accepted 2024/09/04
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSL2400161 | Import | 2024/09/04 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2024/07/12
Import · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHL2400171 | Import | 2024/07/12 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400062 | Import | 2024/03/14 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
Pramipexole Dihydrochloride Prolonged-release Tablets 13 records · Latest accepted 2024/07/04
Supplement · 8Import re-registration · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2400340 | Supplement | 2024/07/04 | Boehringer Ingelheim International GmbH; Rottendorf Pharma GmbH | CDE ↗ |
| JYHB2400339 | Supplement | 2024/07/04 | Boehringer Ingelheim International GmbH; Rottendorf Pharma GmbH | CDE ↗ |
| JYHB2400337 | Supplement | 2024/07/04 | Boehringer Ingelheim International GmbH; Rottendorf Pharma GmbH | CDE ↗ |
| JYHZ2300472 | Import re-registration | 2023/12/29 | Boehringer Ingelheim International GmbH; Rottendorf Pharma GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2300471 | Import re-registration | 2023/12/29 | Boehringer Ingelheim International GmbH; Rottendorf Pharma GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2300470 | Import re-registration | 2023/12/29 | Boehringer Ingelheim International GmbH; Rottendorf Pharma GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2300469 | Import re-registration | 2023/12/29 | Boehringer Ingelheim International GmbH; Rottendorf Pharma GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2300468 | Import re-registration | 2023/12/29 | Boehringer Ingelheim International GmbH; Rottendorf Pharma GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHB2200186 | Supplement | 2022/04/08 | Boehringer Ingelheim International GmbH; Rottendorf Pharma GmbH | CDE ↗ |
| JYHB2200185 | Supplement | 2022/04/08 | Boehringer Ingelheim International GmbH; Rottendorf Pharma GmbH | CDE ↗ |
| JYHB2200184 | Supplement | 2022/04/08 | Boehringer Ingelheim International GmbH; Rottendorf Pharma GmbH | CDE ↗ |
| JYHB2200183 | Supplement | 2022/04/08 | Boehringer Ingelheim International GmbH; Rottendorf Pharma GmbH | CDE ↗ |
| JYHB2200182 | Supplement | 2022/04/08 | Boehringer Ingelheim International GmbH; Rottendorf Pharma GmbH | CDE ↗ |
No verified English name 2 records · Latest accepted 2024/04/11
Import · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHL2400089 | Import | 2024/04/11 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400088 | Import | 2024/04/11 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
No verified English name 24 records · Latest accepted 2024/01/04
Supplement · 9Import · 15
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHB2400006 | Supplement | 2024/01/04 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHB2400005 | Supplement | 2024/01/04 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHB2400004 | Supplement | 2024/01/04 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHL2300195 | Import | 2023/08/22 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300194 | Import | 2023/08/22 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300193 | Import | 2023/08/22 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHB2200169 | Supplement | 2022/11/03 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHB2200168 | Supplement | 2022/11/03 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHB2200167 | Supplement | 2022/11/03 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHL2200207 | Import | 2022/07/20 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2200206 | Import | 2022/07/20 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2200205 | Import | 2022/07/20 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2200074 | Import | 2022/04/01 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2200073 | Import | 2022/04/01 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2200072 | Import | 2022/04/01 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHB2101119 | Supplement | 2021/12/23 | Boehringer Ingelheim International GmbH; Almac Pharma Services Limited | CDE ↗ |
| JXHB2101118 | Supplement | 2021/12/23 | Boehringer Ingelheim International GmbH; Almac Pharma Services Limited | CDE ↗ |
| JXHB2101117 | Supplement | 2021/12/23 | Boehringer Ingelheim International GmbH; Almac Pharma Services Limited | CDE ↗ |
| JXHL2101224 | Import | 2021/10/27 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2101223 | Import | 2021/10/27 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2101222 | Import | 2021/10/27 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2100020 | Import | 2021/01/19 | Boehringer Ingelheim International GmbH | CDE ↗ |
| JXHL2100019 | Import | 2021/01/19 | Boehringer Ingelheim International GmbH | CDE ↗ |
| JXHL2100018 | Import | 2021/01/19 | Boehringer Ingelheim International GmbH | CDE ↗ |
No verified English name 2 records · Latest accepted 2023/12/26
Import · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHL2300328 | Import | 2023/12/26 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300327 | Import | 2023/12/26 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
Telmisartan And Amlodipine Tablets 3 records · Latest accepted 2023/11/25
Supplement · 2Import re-registration · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2300686 | Supplement | 2023/11/25 | Boehringer Ingelheim International GmbH; Cipla Ltd. Goa | CDE ↗ |
| JYHZ2200004 | Import re-registration | 2022/01/07 | Boehringer Ingelheim International GmbH; Cipla Ltd. Goa; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHB2101485 | Supplement | 2021/10/26 | Boehringer Ingelheim International GmbH; Cipla Ltd. Goa | CDE ↗ |
No verified English name 6 records · Latest accepted 2023/10/11
Supplement · 3Import · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHB2300160 | Supplement | 2023/10/11 | Boehringer Ingelheim International GmbH; Almac Pharma Services Limited | CDE ↗ |
| JXHB2300159 | Supplement | 2023/10/11 | Boehringer Ingelheim International GmbH; Almac Pharma Services Limited | CDE ↗ |
| JXHB2300158 | Supplement | 2023/10/11 | Boehringer Ingelheim International GmbH; Almac Pharma Services Limited | CDE ↗ |
| JXHL2200161 | Import | 2022/06/23 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2200160 | Import | 2022/06/23 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2200159 | Import | 2022/06/23 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
No verified English name 3 records · Latest accepted 2023/07/15
Import re-registration · 2Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHZ2300306 | Import re-registration | 2023/07/15 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2300305 | Import re-registration | 2023/07/15 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHB2200425 | Supplement | 2022/08/08 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
No verified English name 3 records · Latest accepted 2023/07/15
Import re-registration · 2Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHZ2300308 | Import re-registration | 2023/07/15 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2300307 | Import re-registration | 2023/07/15 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHB2200426 | Supplement | 2022/08/08 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
No verified English name 3 records · Latest accepted 2023/07/15
Import re-registration · 1Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHZ2300309 | Import re-registration | 2023/07/15 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHB2200427 | Supplement | 2022/08/08 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2101089 | Supplement | 2021/05/11 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
No verified English name 3 records · Latest accepted 2023/07/15
Import re-registration · 1Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHZ2300310 | Import re-registration | 2023/07/15 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHB2200428 | Supplement | 2022/08/08 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2101090 | Supplement | 2021/05/11 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
No verified English name 4 records · Latest accepted 2023/02/22
Supplement · 2Import · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHB2300044 | Supplement | 2023/02/22 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHB2300043 | Supplement | 2023/02/22 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHL2101086 | Import | 2021/06/09 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2100015 | Import | 2021/01/16 | Boehringer Ingelheim International GmbH | CDE ↗ |
No verified English name 4 records · Latest accepted 2022/10/18
Supplement · 2Import · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSB2200130 | Supplement | 2022/10/18 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXSL2101098 | Import | 2021/08/23 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXSB2101037 | Supplement | 2021/07/24 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXSL2101006 | Import | 2021/04/10 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
No verified English name 3 records · Latest accepted 2022/07/18
Supplement · 2Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSB2200095 | Supplement | 2022/07/18 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXSB2200070 | Supplement | 2022/06/13 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXSL2101085 | Import | 2021/08/03 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2021/11/18
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSS2101030 | Import | 2021/11/18 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2021/08/09
Import · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHL2101153 | Import | 2021/08/09 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2101152 | Import | 2021/08/09 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
Changes in the last 90 days
14 events from 2026/08/14 to 2026/11/11. CDE data as of 2026/11/11 06:42; NMPA data as of 2026/11/10 18:31.
This source was last successfully updated at 2026/11/10 18:31; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Accepted: 14 applications
- 2026/11/09Accepted
No verified English name
JXSL2600307
Fact date: 2026/11/09 · Site observation date: 2026/11/10
View source ↗ - 2026/10/13Accepted
No verified English name
JXHL2600448
Fact date: 2026/10/13 · Site observation date: 2026/10/22
View source ↗ - 2026/10/13Accepted
No verified English name
JXHL2600447
Fact date: 2026/10/13 · Site observation date: 2026/10/22
View source ↗ - 2026/10/13Accepted
No verified English name
JXHL2600446
Fact date: 2026/10/13 · Site observation date: 2026/10/22
View source ↗ - 2026/10/13Accepted
No verified English name
JXHL2600445
Fact date: 2026/10/13 · Site observation date: 2026/10/22
View source ↗ - 2026/10/13Accepted
No verified English name
JXHL2600444
Fact date: 2026/10/13 · Site observation date: 2026/10/22
View source ↗ - 2026/10/13Accepted
No verified English name
JXHL2600443
Fact date: 2026/10/13 · Site observation date: 2026/10/22
View source ↗ - 2026/10/13Accepted
No verified English name
JXHL2600442
Fact date: 2026/10/13 · Site observation date: 2026/10/22
View source ↗ - 2026/09/23Accepted
No verified English name
JXHL2600416
Fact date: 2026/09/23 · Site observation date: 2026/10/22
View source ↗ - 2026/09/23Accepted
No verified English name
JXHL2600415
Fact date: 2026/09/23 · Site observation date: 2026/10/22
View source ↗ - 2026/09/23Accepted
No verified English name
JXHL2600414
Fact date: 2026/09/23 · Site observation date: 2026/10/22
View source ↗ - 2026/09/23Accepted
No verified English name
JXHL2600413
Fact date: 2026/09/23 · Site observation date: 2026/10/22
View source ↗ - 2026/09/23Accepted
No verified English name
JXHL2600412
Fact date: 2026/09/23 · Site observation date: 2026/10/22
View source ↗ - 2026/09/03Accepted
No verified English name
JXHL2600392
Fact date: 2026/09/03 · Site observation date: 2026/10/22
View source ↗
Under review
23 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| No verified English name | JXSL2600307 | Import | 2026/11/09 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| No verified English name | JXHL2600448 | Import | 2026/10/13 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| No verified English name | JXHL2600447 | Import | 2026/10/13 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| No verified English name | JXHL2600446 | Import | 2026/10/13 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| No verified English name | JXHL2600445 | Import | 2026/10/13 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| No verified English name | JXHL2600444 | Import | 2026/10/13 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| No verified English name | JXHL2600443 | Import | 2026/10/13 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| No verified English name | JXHL2600442 | Import | 2026/10/13 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| No verified English name | JXHL2600416 | Import | 2026/09/23 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| No verified English name | JXHL2600415 | Import | 2026/09/23 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| No verified English name | JXHL2600414 | Import | 2026/09/23 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| No verified English name | JXHL2600413 | Import | 2026/09/23 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| No verified English name | JXHL2600412 | Import | 2026/09/23 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| No verified English name | JXHL2600392 | Import | 2026/09/03 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| Nintedanib Esilate Soft Capsules | JYHZ2600193 | Import re-registration | 2026/08/12 | Boehringer Ingelheim International GmbH; Catalent Germany Eberbach GmbH | CDE ↗ |
| Nintedanib Esilate Soft Capsules | JYHZ2600192 | Import re-registration | 2026/08/12 | Boehringer Ingelheim International GmbH; Catalent Germany Eberbach GmbH | CDE ↗ |
| Afatinib Dimaleate Tablets | JYHB2600436 | Supplement | 2026/08/05 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| Afatinib Dimaleate Tablets | JYHB2600435 | Supplement | 2026/08/05 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| Dabigatran Etexilate Capsules | JYHB2600154 | Supplement | 2026/03/10 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co.KG | CDE ↗ |
| Dabigatran Etexilate Capsules | JYHB2600153 | Supplement | 2026/03/10 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co.KG | CDE ↗ |
| Nintedanib Esilate Soft Capsules | JYHB2500616 | Supplement | 2025/11/12 | Boehringer Ingelheim International GmbH; Catalent Germany Eberbach GmbH; Catalent France Beinheim | CDE ↗ |
| Nintedanib Esilate Soft Capsules | JYHB2500615 | Supplement | 2025/11/12 | Boehringer Ingelheim International GmbH; Catalent Germany Eberbach GmbH; Catalent France Beinheim | CDE ↗ |
| No verified English name | JYHB2500306 | Supplement | 2025/06/06 | Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim Espa？a S.A. | CDE ↗ |
Catalogue holder records
18 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/11 06:38. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| No verified English name | Boehringer Ingelheim International GmbH | Boehringer Ingelheim Pharma GmbH & Co. KG | H20180058 | 2018/10/15 | Imported originator drug | CDE ↗ |
| No verified English name | Boehringer Ingelheim International GmbH | Boehringer Ingelheim Pharma GmbH & Co.KG | H20180037 | 2018/07/18 | Imported originator drug | CDE ↗ |
| Empagliflozin Tablets | Boehringer Ingelheim International GmbH | Boehringer Ingelheim Pharma GmbH & Co. KG | H20170351 | 2017/09/20 | Imported originator drug | CDE ↗ |
| Nintedanib Esilate Soft Capsules | Boehringer Ingelheim International GmbH | Catalent Germany Eberbach GmbH | H20170355 | 2017/09/20 | Imported originator drug | CDE ↗ |
| Nintedanib Esilate Soft Capsules | Boehringer Ingelheim International GmbH | Catalent Germany Eberbach GmbH | H20170354 | 2017/09/20 | Imported originator drug | CDE ↗ |
| Afatinib Dimaleate Tablets | Boehringer Ingelheim International GmbH | Boehringer Ingelheim Pharma GmbH & Co. KG | H20170066;H20170067 | 2017/02/21 | Imported originator drug | CDE ↗ |
| Afatinib Dimaleate Tablets | Boehringer Ingelheim International GmbH | Boehringer Ingelheim Pharma GmbH & Co. KG | H20170068;H20170069 | 2017/02/21 | Imported originator drug | CDE ↗ |
| Pramipexole Dihydrochloride Prolonged-release Tablets | Boehringer Ingelheim International GmbH | Boehringer Ingelheim Pharm GmbH & Co. KG | H20140583;H20140584 | 2014/08/01 | Imported originator drug | CDE ↗ |
| Pramipexole Dihydrochloride Prolonged-release Tablets | Boehringer Ingelheim International GmbH | Boehringer Ingelheim Pharm GmbH & Co. KG | H20140579;H20140580 | 2014/08/01 | Imported originator drug | CDE ↗ |
| Linagliptin Tablets | Boehringer Ingelheim International GmbH | West-Ward Columbus Inc. | H20171166;H20171167;H20171168;H20171169 | 2013/03/26 | Imported originator drug | CDE ↗ |
| Dabigatran Etexilate Capsules | Boehringer Ingelheim International GmbH | Boehringer Ingelheim Pharma GmbH & Co.KG | H20170148; H20170135 | 2013/02/22 | Imported originator drug | CDE ↗ |
| Dabigatran Etexilate Capsules | Boehringer Ingelheim International GmbH | Boehringer Ingelheim Pharma GmbH & Co.KG | H20170149; H20170136 | 2013/02/22 | Imported originator drug | CDE ↗ |
| Telmisartan and Hydrochlorothiazide Tablets | Boehringer Ingelheim International GmbH | Boehringer Ingelheim Pharma GmBH& Co. KG | H20171206;H20171207;H20171208 | 2008/12/19 | Imported originator drug | CDE ↗ |
| Pramipexole Dihydrochloride Tablets | Boehringer Ingelheim International GmbH | Boehringer Ingelheim Pharm GmbH & Co. KG | H20140917 | 2005/12/30 | Imported originator drug | CDE ↗ |
| Pramipexole Dihydrochloride Tablets | Boehringer Ingelheim International GmbH | Boehringer Ingelheim Pharm GmbH & Co. KG | H20140918 | 2005/12/30 | Imported originator drug | CDE ↗ |
| Tiotropium Bromide Powder For Inhalation | Boehringer Ingelheim International GmbH | Boehringer Ingelheim Pharma GmbH & Co. KG | H20140933;H20140954 | 2005/05/10 | Imported originator drug | CDE ↗ |
| Telmisartan Tablets | Boehringer Ingelheim International GmbH | Boehringer Ingelheim Pharma GmbH & Co.KG | H20150134; H20150135 | 2001/09/06 | Imported originator drug | CDE ↗ |
| Telmisartan Tablets | Boehringer Ingelheim International GmbH | Boehringer Ingelheim Pharma GmbH & Co.KG | H20150137; H20150138 | 2001/09/06 | Imported originator drug | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
0 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/11 06:40.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| No matching records were found in the currently loaded source data; coverage dates are listed below. | |||||
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
18 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| No verified English name | JTH2600177 | Not stated by source | 2026/08/24 | Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim International GmbH; Bo Lin Ge Yin Ge Han (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2600170 | Not stated by source | 2026/08/12 | Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim International GmbH; Bo Lin Ge Yin Ge Han (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2600060 | Not stated by source | 2026/03/21 | Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim International GmbH; Bo Lin Ge Yin Ge Han (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2400188 | Not stated by source | 2024/11/08 | Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim International GmbH; Bo Lin Ge Yin Ge Han (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| Telmisartan Tablets | JTH2400169 | Not stated by source | 2024/10/08 | Name not romanized; Boehringer Ingelheim International GmbH; Tianjin Shi Kang Rui Pharma Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2400085 | Not stated by source | 2024/06/18 | Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim International GmbH; Bo Lin Ge Yin Ge Han (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2400072 | Not stated by source | 2024/05/17 | Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim International GmbH; Bo Lin Ge Yin Ge Han (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2400071 | Not stated by source | 2024/05/17 | Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim International GmbH; Bo Lin Ge Yin Ge Han (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2400063 | Not stated by source | 2024/05/08 | Hovione FarmaCiencia SA; Boehringer Ingelheim International GmbH; Bo Lin Ge Yin Ge Han (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2300212 | Not stated by source | 2023/09/06 | Almac Pharma Services Limited; Boehringer Ingelheim International GmbH; Bo Lin Ge Yin Ge Han (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2300211 | Not stated by source | 2023/09/06 | Almac Pharma Services Limited; Boehringer Ingelheim International GmbH; Bo Lin Ge Yin Ge Han (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2300210 | Not stated by source | 2023/09/06 | Almac Pharma Services Limited; Boehringer Ingelheim International GmbH; Bo Lin Ge Yin Ge Han (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| Telmisartan Tablets | JTH2300198 | Not stated by source | 2023/08/21 | Name not romanized; Boehringer Ingelheim International GmbH; Tianjin Shi Kang Rui Pharma Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2300157 | Not stated by source | 2023/06/27 | Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim International GmbH; Bo Lin Ge Yin Ge Han (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2300001 | Not stated by source | 2023/01/11 | Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim International GmbH; Bo Lin Ge Yin Ge Han (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2100722 | Not stated by source | 2021/12/16 | Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim International GmbH; Bo Lin Ge Yin Ge Han (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2100693 | Not stated by source | 2021/11/22 | Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim International GmbH; Bo Lin Ge Yin Ge Han (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2100501 | Not stated by source | 2021/05/17 | Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer Ingelheim International GmbH; Bo Lin Ge Yin Ge Han (Zhongguo) Investment Co., Ltd. romanized | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/11 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/11 06:38
- Full API register
- Last successful update: 2026/11/11 06:40
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31 · Current coverage may be incomplete
First index-page publication dates: — to —; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only, without new source queries or collection. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Drug names use verified official English names only. Missing names are shown as No verified English name, linking to a Chinese page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized. Original statutory reference numbers are the sole visible Chinese exception.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Chinese free text is not displayed; use the source links or source-name columns in CSV exports.